SG11201401084TA - Anti-viral compounds - Google Patents

Anti-viral compounds

Info

Publication number
SG11201401084TA
SG11201401084TA SG11201401084TA SG11201401084TA SG11201401084TA SG 11201401084T A SG11201401084T A SG 11201401084TA SG 11201401084T A SG11201401084T A SG 11201401084TA SG 11201401084T A SG11201401084T A SG 11201401084TA SG 11201401084T A SG11201401084T A SG 11201401084TA
Authority
SG
Singapore
Prior art keywords
anti
viral compounds
viral
compounds
Prior art date
Application number
SG11201401084TA
Inventor
Shawn P Iadonato
Kristin Bedard
Myra Wang Imanaka
Kerry W Fowler
Original Assignee
Kineta Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201161542049P priority Critical
Application filed by Kineta Inc filed Critical Kineta Inc
Priority to PCT/US2012/057646 priority patent/WO2013049407A2/en
Publication of SG11201401084TA publication Critical patent/SG11201401084TA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/428Thiazoles condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y02A50/38Medical treatment of vector-borne diseases characterised by the agent
    • Y02A50/381Medical treatment of vector-borne diseases characterised by the agent the vector-borne disease being caused by a virus
    • Y02A50/384Medical treatment of vector-borne diseases characterised by the agent the vector-borne disease being caused by a virus of the genus Flavivirus
    • Y02A50/385Medical treatment of vector-borne diseases characterised by the agent the vector-borne disease being caused by a virus of the genus Flavivirus the disease being Dengue
SG11201401084TA 2011-09-30 2012-09-27 Anti-viral compounds SG11201401084TA (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US201161542049P true 2011-09-30 2011-09-30
PCT/US2012/057646 WO2013049407A2 (en) 2011-09-30 2012-09-27 Anti-viral compounds

Publications (1)

Publication Number Publication Date
SG11201401084TA true SG11201401084TA (en) 2014-04-28

Family

ID=47996748

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201401084TA SG11201401084TA (en) 2011-09-30 2012-09-27 Anti-viral compounds

Country Status (17)

Country Link
US (2) US9555106B2 (en)
EP (1) EP2748172B1 (en)
JP (2) JP2014528412A (en)
KR (1) KR20140070631A (en)
CN (1) CN103857683B (en)
AP (1) AP201407595A0 (en)
AU (3) AU2012315953A1 (en)
BR (1) BR112014007599A2 (en)
CA (1) CA2859946A1 (en)
HK (1) HK1199029A1 (en)
IL (1) IL231780A (en)
MX (1) MX351818B (en)
NZ (1) NZ622636A (en)
SG (1) SG11201401084TA (en)
TW (1) TW201326163A (en)
WO (1) WO2013049407A2 (en)
ZA (1) ZA201401825B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201401084TA (en) 2011-09-30 2014-04-28 Kineta Inc Anti-viral compounds
US9073946B2 (en) * 2013-01-15 2015-07-07 Kineta, Inc. Anti-viral compounds
AU2015255714A1 (en) * 2014-05-09 2016-10-20 Kineta, Inc. Anti-viral compounds, pharmaceutical compositions, and methods of use thereof
US20180312536A1 (en) 2017-04-14 2018-11-01 Solstice Biologics, Ltd. Immunomodulating polynucleotides, antibody conjugates thereof, and methods of their use

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3489558A (en) * 1967-09-18 1970-01-13 Ibm Photoconductive benzobisthiazoles and their use in electrophotographic processes
JPH0260172B2 (en) * 1984-03-29 1990-12-14 Mitsubishi Seishi Kk
JPS63190880A (en) * 1986-09-09 1988-08-08 Nippon Tokushu Noyaku Seizo Kk Novel n-benzothiazolyl-amides and insecticide
US4940722A (en) * 1986-12-10 1990-07-10 Sumitomo Chemical Companmy, Limited Seed disinfectant composition
JPS63270608A (en) * 1986-12-10 1988-11-08 Sumitomo Chem Co Ltd Seed disinfectant
IL90337D0 (en) * 1988-05-24 1989-12-15 Pfizer Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents
DK0706514T3 (en) * 1993-08-24 1999-08-02 Medivir Ab Compounds and methods for inhibition of HIV and related viruses
US6310211B1 (en) * 1996-09-10 2001-10-30 Pharmacia & Upjohn Company 8-hydroxy-7-substituted quinolines as anti-viral agents
RU2223761C2 (en) * 1999-12-27 2004-02-20 Джапан Тобакко Инк. Ring-condensed compounds and their using as medicinal agents
JP3972167B2 (en) * 2000-01-26 2007-09-05 株式会社大塚製薬工場 Phosphonic acid diester derivatives
PL357099A1 (en) * 2000-02-07 2004-07-12 Abbott Gmbh & Co.Kg 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
WO2001070705A1 (en) * 2000-03-17 2001-09-27 Alcon, Inc. 2-acylaminobenzimidazole derivatives for treating glaucoma
US7122544B2 (en) * 2000-12-06 2006-10-17 Signal Pharmaceuticals, Llc Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
JP4038665B2 (en) * 2002-06-19 2008-01-30 株式会社大塚製薬工場 Phosphonic acid diester derivatives
WO2004078115A2 (en) * 2003-02-28 2004-09-16 Viropharma, Incorporated Benzothiazole compounds, compositions and methods for treatment and prophylaxis of rotavirus infections and associated diseases
EP1608369B1 (en) * 2003-03-28 2013-06-26 Novartis Vaccines and Diagnostics, Inc. Use of organic compounds for immunopotentiation
US20050130974A1 (en) * 2003-10-17 2005-06-16 Rigel Pharmaceuticals, Inc. Benzothiazole compositions and their use as ubiquitin ligase inhibitors
EA012607B1 (en) * 2004-09-20 2009-10-30 4Сц Аг NOVEL HETEROCYCLIC NF-kB INHIBITORS
US20100267717A1 (en) 2005-07-29 2010-10-21 4Sc Ag Novel Heterocyclic NF-kB Inhibitors
CA2646223A1 (en) * 2006-03-15 2007-09-20 4Sc Ag Novel heterocyclic nf-kb inhibitors
GB0421908D0 (en) * 2004-10-01 2004-11-03 Angeletti P Ist Richerche Bio New uses
CN101247807A (en) * 2005-05-09 2008-08-20 艾其林医药公司 Thiazole compounds and methods of use
CA2628863A1 (en) * 2005-10-06 2007-04-19 University Of Massachusetts Composition and synthesis of new reagents for inhibition of hiv replication
TW200730478A (en) * 2005-12-12 2007-08-16 Genelabs Tech Inc N-(6-membered aromatic ring)-amido anti-viral compounds
JP2010506948A (en) * 2006-10-20 2010-03-04 アイアールエム・リミテッド・ライアビリティ・カンパニーIrm,Llc Compositions and methods for modulating the C-kit and pdgfr receptor
WO2008141385A1 (en) * 2007-05-21 2008-11-27 Biota Scientific Management Pty Ltd Viral polymerase inhibitors
RS55735B1 (en) * 2007-08-03 2017-07-31 Summit (Oxford) Ltd Drug combinations for the treatment of duchenne muscular dystrophy
BRPI0818598A2 (en) * 2007-10-10 2017-05-16 Astrazeneca Ab therapeutic agents - 802
WO2010008847A2 (en) * 2008-06-24 2010-01-21 Takeda Pharmaceutical Company Limited Pi3k/m tor inhibitors
WO2010024903A1 (en) * 2008-08-29 2010-03-04 Yangbo Feng BENZO[d]OXAZOLES AND BENZO[d]THIAZOLES AS KINASE INHIBITORS
GB0820856D0 (en) * 2008-11-14 2008-12-24 Univ Leuven Kath Novel inhibitors of flavivirus replication
PA8854001A1 (en) * 2008-12-16 2010-07-27 Abbott Lab novel compounds as cannabinoid receptor ligands
CN104856991A (en) * 2009-02-27 2015-08-26 西佳技术公司 Thienopyridine derivatives for the treatment and prevention of dengue virus infections
WO2010100144A1 (en) * 2009-03-04 2010-09-10 Merck Serono S.A. Fused bicyclic compounds as inhibitors for pi3 kinase
US8338441B2 (en) * 2009-05-15 2012-12-25 Gilead Sciences, Inc. Inhibitors of human immunodeficiency virus replication
WO2010144909A1 (en) * 2009-06-12 2010-12-16 Novartis Ag Fused heterocyclic compounds and their uses
AP201206094A0 (en) 2009-06-30 2012-02-29 Siga Technologies Inc Treatment and prevention of dengue virus infections.
WO2011006158A2 (en) * 2009-07-10 2011-01-13 University Of Maryland, Baltimore Targeting nad biosynthesis in bacterial pathogens
WO2011022721A1 (en) * 2009-08-21 2011-02-24 Microbiotix, Inc Inhibitors of botulinum neurotoxins
SG11201401084TA (en) 2011-09-30 2014-04-28 Kineta Inc Anti-viral compounds

Also Published As

Publication number Publication date
AU2012315953A1 (en) 2014-04-03
US9956285B2 (en) 2018-05-01
NZ622636A (en) 2016-07-29
IL231780D0 (en) 2014-05-28
US20170258897A1 (en) 2017-09-14
HK1199029A1 (en) 2015-06-19
AU2017254812A1 (en) 2017-11-16
AP201407595A0 (en) 2014-04-30
WO2013049407A3 (en) 2013-05-30
WO2013049407A2 (en) 2013-04-04
EP2748172A2 (en) 2014-07-02
ZA201401825B (en) 2017-08-30
TW201326163A (en) 2013-07-01
AU2017210483A1 (en) 2017-08-17
CA2859946A1 (en) 2013-04-04
BR112014007599A2 (en) 2017-04-11
EP2748172B1 (en) 2017-12-06
JP2017222656A (en) 2017-12-21
MX351818B (en) 2017-10-30
US20140227320A1 (en) 2014-08-14
US9555106B2 (en) 2017-01-31
CN103857683A (en) 2014-06-11
AU2017254812B2 (en) 2018-07-19
IL231780A (en) 2017-08-31
EP2748172A4 (en) 2015-10-14
KR20140070631A (en) 2014-06-10
JP2014528412A (en) 2014-10-27
CN103857683B (en) 2016-10-12
MX2014003887A (en) 2014-11-21

Similar Documents

Publication Publication Date Title
TWI600852B (en) Chainring
TWI419874B (en) Anti-viral compounds
TWI613199B (en) Compounds
TWI572700B (en) Bimesogenic compounds
TWI588141B (en) Substituted benzylindazoles
GB201114103D0 (en) Novel compounds
SG10201601802YA (en) Dispiropyrrolidine derivatives
HK1195016A1 (en) Protein-polymer-drug conjugates --
IL226345D0 (en) Antiviral compounds
EP2743256A4 (en) Cyclopropaneamine compound
GB201106799D0 (en) Novel compounds
IL222634D0 (en) Anti-viral compounds
TWI586660B (en) Anti-viral compounds
GB201107325D0 (en) Novel compounds
GB201118652D0 (en) New compounds
HK1203196A1 (en) Substituted benzylpyrazoles
GB201106395D0 (en) Compounds
TWI561522B (en) Substituted imidazopyridinyl-aminopyridine compounds
EP2755962A4 (en) Azaindazoles
HK1199028A1 (en) Anti-viral compounds
GB201118654D0 (en) New compounds
LT2776436T (en) New compounds
GB201116641D0 (en) Novel compounds
EP2651926A4 (en) Anti-viral compounds
GB201112607D0 (en) Novel compounds